Literature DB >> 9881252

Percutaneous intentional extraluminal (subintimal) recanalization of crural arteries.

A Bolia1.   

Abstract

Patients with critical limb ischaemia (CLI) often have occlusive disease of the crural arteries. Therefore attempts at treating CLI by minimally invasive means has to be directed towards recanalization of occluded crural arteries. Subintimal angioplasty of long occlusions of the crural arteries is safe and effective and is therefore an excellent alternative to reconstructive surgery in patients who are frequently elderly and frail. It is also relatively cheap when compared to bypass surgery.

Entities:  

Mesh:

Year:  1998        PMID: 9881252     DOI: 10.1016/s0720-048x(98)00115-6

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  5 in total

1.  Hydrodynamic boost: a novel re-entry technique in subintimal angioplasty of below-the-knee vessels.

Authors:  Roberto Ferraresi; Meneme Hamade; Vito Gallicchio; Nicola Troisi; Giovanni Mauri
Journal:  Eur Radiol       Date:  2015-11-11       Impact factor: 5.315

2.  Subintimal angioplasty in the treatment of chronic lower limb ischemia.

Authors:  Sung Ki Cho; Young Soo Do; Sung Wook Shin; Kwang Bo Park; Dong-Ik Kim; Young Wook Kim; Duk-Kyung Kim; Sung Wook Choo; In Wook Choo
Journal:  Korean J Radiol       Date:  2006 Apr-Jun       Impact factor: 3.500

Review 3.  Peripheral arterial disease: clinical assessment and indications for revascularization in the patient with diabetes.

Authors:  Bart E Muhs; Paul Gagne; Peter Sheehan
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

4.  Alternative crossing technique for iliaco-femoro-popliteal CTOs with a catheter only.

Authors:  Marc Cunier; Arash Najafi; Gabriel T Sheikh; Christoph A Binkert
Journal:  CVIR Endovasc       Date:  2019-07-18

5.  Retrograde distal superficial femoral artery approach in the supine position for chronic superficial femoral artery occlusion.

Authors:  Sanghoon Shin; Seunghwan Kim; Young-Guk Ko; Myeung-Ki Hong; Yangsoo Jang; Donghoon Choi
Journal:  Korean Circ J       Date:  2014-05-20       Impact factor: 3.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.